Skip to content
healthcare.dev

Dantrium

NDC 42023-123, dantrolene sodium, injection, from Par Health USA, LLC.

Product NDC
42023-123
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA018264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42023-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DANTROLENE SODIUM20 mg/60mL

Pharmacologic classes

Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]

Package NDCNDC-11Package
42023-123-06420230123066 VIAL in 1 CARTON (42023-123-06) / 60 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4df35098-8702-46be-ac67-30cfdf1aa570

Use it

Look up 42023-123 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42023-123 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42023-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.